# SYRINGEX MEDICAL INC — Form D

SYRINGEX MEDICAL INC of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2010-12-03. Industry: Other Health Care.

## Offering

- Filed: 2010-12-03
- Form: D
- Accession: 0001165527-10-000931
- Industry: Other Health Care
- Exemptions: 06
- Minimum investment: $1K
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-151339

## Issuer

- Name: SYRINGEX MEDICAL INC
- CIK: 0001065524
- Entity type: Corporation
- Jurisdiction: NEVADA
- Address: 48 WALL STREET, NEW YORK, NY, 10005
- Phone: 212-918-4606

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Robert Kevin Beauregard | Director | New York, NY |
| Vincent J Giovinazzo | Director | New York, NY |
| KELLY T HICKEL | Director | NEW YORK, NY |
| Nachum Max Shemesh | Director | New York, NY |
| Robert Kevin Beauregard | Executive Officer | New York, NY |
| KELLY T HICKEL | Executive Officer | NEW YORK, NY |
| Nachum Max Shemesh | Executive Officer | New York, NY |

## More

- [CIK 1065524 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1065524&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001165527-10-000931.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.